PCUK_Co_Small_BlueBG_CMYK

First Page		Document Content
Date: 2013-09-04 14:45:16 Anilides Organofluorides GnRH agonists Androgens Prostate cancer Degarelix Testosterone Bicalutamide Hormone therapy Medicine Endocrine system Antiandrogens		PCUK_Co_Small_BlueBG_CMYK Add to Reading List Source URL: www.prostate.org.nz Download Document from Source Website File Size: 335,48 KB Share Document on Facebook

	Microsoft Word - DSU Degarelix FINAL sent to NICE DocID: 1oZJA - View Document
	16 SeptemberProhibited List Summary of Major Modifications and Explanatory Notes SUBSTANCES AND METHODS PROHIBITED AT ALL TIMES (IN- AND OUT-OFCOMPETITION) PROHIBITED SUBSTANCES DocID: 1nvS9 - View Document
	Kwartaalbericht 3e kwartaaldecember 2002 Contents DocID: 15NH9 - View Document
	State of Vermont Department of Vermont Health Access 312 Hurricane Lane, Suite 201 Williston, VTwww.dvha.vermont.gov DocID: 13avT - View Document
	Public Summary Document – November 2014 PBAC Meeting 6.7 LEUPRORELIN 30 mg injection: modified release [1 x 30 mg syringe] (&) DocID: 12zdb - View Document